Opinion
Video
Author(s):
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, have a comprehensive discussion on treatment safety considerations for patients with atopic dermatitis who are breastfeeding.
Dupilumab in Hyper-IgE Syndrome: A Case Series of Pediatric Patients
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Experts Delve Into Upadacitinib vs Dupilumab: Insights From LEVEL UP
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas
Q+A: Roflumilast cream 0.15% for AD with Eric Simpson, MD, MCR, FAAD